Automate Your Wheel Strategy on LFMD
With Tiblio's Option Bot, you can configure your own wheel strategy including LFMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LFMD
- Rev/Share 5.2351
- Book/Share 0.0086
- PB -126.0392
- Debt/Equity -12.3715
- CurrentRatio 0.7717
- ROIC 0.2657
- MktCap 239932009.0
- FreeCF/Share 0.2988
- PFCF 18.0875
- PE -33.5112
- Debt/Assets 0.2998
- DivYield 0
- ROE 1.5486
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | LFMD | BTIG Research | -- | Buy | $15 | $18 | June 18, 2025 |
| Initiation | LFMD | Lake Street | -- | Buy | -- | $12 | Dec. 10, 2024 |
| Initiation | LFMD | Mizuho | -- | Neutral | -- | $7 | Dec. 4, 2024 |
| Resumed | LFMD | B. Riley Securities | -- | Buy | -- | $11 | Aug. 23, 2024 |
News
LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform
Published: November 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
Transaction Values WorkSimpli at $65 Million Enterprise Value; Supports LifeMD's Strategic Focus on Scaling its Virtual Care and Pharmacy Businesses Transaction Values WorkSimpli at $65 Million Enterprise Value; Supports LifeMD's Strategic Focus on Scaling its Virtual Care and Pharmacy Businesses
Read More
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now?
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Hims & Hers and LifeMD are reshaping virtual care, but which one leads in earnings growth and platform scale? Let's dive in.
Read More
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: October 27, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)---- $LFMD--LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
Read More
LFMD FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of LifeMD Upcoming Lead Plaintiff Deadline on Monday, October 27, 2025
Published: October 27, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $LFMD #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) and reminds investors of the October 27, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has r.
Read More
LifeMD Deadline: LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
Published: October 26, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Oct. 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased LifeMD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: October 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising --- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) and certain of its officers.
Read More
MONDAY DEADLINE: Berger Montague Advises LifeMD, Inc. (NASDAQ: LFMD) Investors to Inquire About a Securities Fraud Class Action by October 27, 2025
Published: October 24, 2025 by: PRNewsWire
Sentiment: Neutral
PHILADELPHIA , Oct. 24, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025 , seek to be appointed as a lead plaintiff representative of the class.
Read More
LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman
Published: October 24, 2025 by: PRNewsWire
Sentiment: Neutral
LFMD Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline SAN FRANCISCO , Oct. 24, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
Published: October 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: October 23, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , Oct. 23, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Read More
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Published: October 23, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding In LifeMD To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD" or the …
Read More
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: October 22, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Oct. 22, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) have opportunity to lead the securities fraud class action lawsuit.
Read More
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: October 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising --- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) and certain of its officers.
Read More
Shareholders that lost money on LifeMD, Inc.(LFMD) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Published: October 21, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LifeMD, Inc. investors who were adversely affected by alleged securities fraud between May 7, 2025 and August 5, 2025.
Read More
LFMD 6-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
Published: October 21, 2025 by: PRNewsWire
Sentiment: Neutral
LFMD Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline SAN FRANCISCO , Oct. 21, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines – LFMD
Published: October 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman
Published: October 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
LFMD Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline LFMD Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline
Read More
LFMD 9-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
Published: October 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
LFMD Investors with Losses Encouraged to Contact the Firm Before Oct. 27th Deadline LFMD Investors with Losses Encouraged to Contact the Firm Before Oct. 27th Deadline
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
Published: October 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman
Published: October 17, 2025 by: PRNewsWire
Sentiment: Neutral
LFMD Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline SAN FRANCISCO , Oct. 17, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report.
Read More
Faruqi & Faruqi Reminds LifeMD Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 27, 2025 - LFMD
Published: October 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding In LifeMD To Contact Him Directly To Discuss Their Options
Read More
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: October 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising --- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) and certain of its officers.
Read More
LifeMD, Inc. (NASDAQ: LFMD) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
Published: October 15, 2025 by: PRNewsWire
Sentiment: Neutral
PHILADELPHIA , Oct. 15, 2025 /PRNewswire/ -- Berger Montague PC , national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025 , seek to be appointed as a lead plaintiff representative of the class.
Read More
LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman
Published: October 15, 2025 by: Business Wire
Sentiment: Neutral
SAN FRANCISCO--(BUSINESS WIRE)--A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report. The firm urges investors in LifeMD who suffered significant losses to submi.
Read More
LFMD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Published: October 15, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 15, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) …
Read More
Deadline Alert: LifeMD, Inc. (LFMD) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: October 14, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 27, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”).
Read More
LFMD 13-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
Published: October 14, 2025 by: PRNewsWire
Sentiment: Neutral
LFMD Investors with Losses Encouraged to Contact the Firm Before Oct. 27th Deadline SAN FRANCISCO , Oct. 14, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
Published: October 13, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (NASDAQ: LFMD)
Published: October 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) between May 7 , 202 5 and August 5 , 202 5, inclusive. Should You Join This Class Action Lawsuit?
Read More
LIFEMD (LFMD) ALERT: Bragar Eagel & Squire, P.C. Reminds LifeMD Investors of the October 27th Deadline in the Filed LifeMD Class Action Lawsuit
Published: October 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
The complaint alleges LifeMD overstated its strength and raised 2025 guidance without factoring rising customer costs, making its statements misleading.
Read More
About LifeMD, Inc. (LFMD)
- IPO Date 2008-01-29
- Website https://www.lifemd.com
- Industry Medical - Pharmaceuticals
- CEO Justin Schreiber
- Employees 304